Table 7.
Calculation of viral safety margins
| HIV | HCV | HBV | HAV | Parvovirus | |
|---|---|---|---|---|---|
| Viral load (log; from Table 1) | 5.7 | 6.0 | 4.4 | 2.9 | 6.6 |
| Fibrinogen | |||||
| Viral clearance capacity (log) | 17.5 | 17.5 | 15.5 | 10.3 | 6.8 |
| Safety margin (fold) | 6.3 × 1011 | 3.2 × 1011 | 1.3 × 1011 | 2.5 × 107 | 1.6 |
| Risk/vial (with virus at maximum load)* | 3 × 10−16 | 5 × 10−16 | 1 × 10−15 | 7 × 10−12 | 1 × 10−4 |
| Adjusted risk/vial (all lots)† | 1 × 10−19 | 3 × 10−19 | 5 × 10−17 | 2 × 10−16 | 2 × 10−6 |
| Thrombin | |||||
| Viral clearance capacity (log) | 18 | 19 | 17 | 11 | 7.3‐9.9 |
| Safety margin (fold) | 2 × 1012 | 1 × 1013 | 4 × 1012 | 1 × 108 | 2 × 103 |
| Risk/vial (with virus at maximum load)‡ | 8 × 10−18 | 2 × 10−18 | 4 × 10−18 | 1 × 10−13 | 3 × 10−6‐8 × 10−9 § |
| Adjusted risk/vial (all lots)† | 4 × 10−21 | 8 × 10−22 | 2 × 10−19 | 3 × 10−18 | 7 × 10−8‐2 × 10−10 § |
Assumes 1 vial per L of plasma.
The risk was adjusted to include lots without virus (calculated from Table 1, Column 4) and further assumes that the average viral load of contaminated lots is 1 log lower than the maximum load.
Assumes 10 vials per L of plasma.
The larger number applies to Baxter's thrombin and the smaller number applies to Omrix's thrombin.